Skip to content
DraconiticResearch
Search Sources API
206,690 studies31 sourcesUpdated 38 min ago
Peer-reviewedCC BY 4.0eClinicalMedicine

The use of appropriate, inappropriate and no comparators in efficacy trials for European Medicines Agency-approved drugs 2011–2024: a retrospective cohort study

Related

  1. Selecting Vehicle Comparators in Dry Eye Disease Clinical Trials: Implications for Efficacy and Safety Assessment and Regulatory Outcomes
    Isabella Tunon-Robinson, Suzanne Zheng, Cathy Zhao +2
    Ophthalmology and TherapyPeer-reviewedCC BY-NCFull textEpidemiology & public healthDOAJ
  2. Sex representation and assessment of sex-related differences in central nervous system medicine development: a retrospective cross-sectional study of European Medicines Agency marketing authorisation dossiers (2012–2022)
    Sam Schoenmakers, Charlotte Bakker, Alexandra Ganev +2
    BMJ OpenPeer-reviewedLicence not statedGeneral medicineCrossref
  3. Toxic traditional Chinese medicines as hormetic immunomodulators in cancer: from toxicity-efficacy homology to translational opportunities
    Qing Tong, Zhiqiang Cai
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMCEurope PMC
  4. Effect of inappropriate empirical antimicrobial therapy on time to hospital discharge in patients with community-acquired acute pyelonephritis: a propensity score-weighted retrospective cohort study.
    Sebastián Salinas-Mendoza, Álvaro Javier Burgos Cárdenas, Estivalis Geraldine Acosta Gutierrez +1
    BMC infectious diseasesPeer-reviewedCC BY-NC-NDFull textEpidemiology & public healthEurope PMCDOAJ
  5. Association between health empowerment and medication literacy among older adults with coronary heart disease after PCI: the mediating role of self-efficacy for appropriate medication use
    Yuting Fan, Yuxin Li, Xipei Chen +4
    Frontiers in Public HealthPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefEurope PMC
BibTeX
@article{glaus2026appropriate,
  title = {{The use of appropriate, inappropriate and no comparators in efficacy trials for European Medicines Agency-approved drugs 2011–2024: a retrospective cohort study}},
  author = {Camille E.G. Glaus and Cascal Herrle and Simon Hediger and Kerstin Noelle Vokinger},
  journal = {eClinicalMedicine},
  year = {2026},
  month = nov,
  doi = {10.1016/j.eclinm.2026.104319},
  url = {https://linkinghub.elsevier.com/retrieve/pii/S2589537026005729},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - The use of appropriate, inappropriate and no comparators in efficacy trials for European Medicines Agency-approved drugs 2011–2024: a retrospective cohort study
AU  - Camille E.G. Glaus
AU  - Cascal Herrle
AU  - Simon Hediger
AU  - Kerstin Noelle Vokinger
PY  - 2026
DA  - 2026/11/01
JO  - eClinicalMedicine
DO  - 10.1016/j.eclinm.2026.104319
UR  - https://linkinghub.elsevier.com/retrieve/pii/S2589537026005729
SN  - 2589-5370
ER  -